Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.11.037Source: DataRank Database

Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis is a research paper published in Transplantation and Cellular Therapy (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.36)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Glenn Heller ORCID,Christina Cho ORCID,Joshua Fein ORCID,Parastoo B. Dahi ORCID,Gunjan L. Shah ORCID

Live enrichment

PubMed:41319917 PMC:PMC12721594 OpenAlex:https://openalex.org/W4416795677

National Cancer Institute

Grant: P30 CA008748

National Institutes of Health

FWCI

0.36

Citation Percentile

0.6%

Citation Trend

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12721594/

publisherhttps://api.elsevier.com/content/article/PII:S2666636725016136?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636725016136?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtct.2025.11.037

Fields of Study

Complement system in diseasesHematopoietic Stem Cell TransplantationRenal Transplantation Outcomes and TreatmentsHumansThrombotic MicroangiopathiesFemaleMaleAdultMiddle AgedRetrospective StudiesAntibodies, Monoclonal, HumanizedComplement Inactivating AgentsTreatment OutcomeYoung Adult

MeSH Terms

AdultFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeHematopoietic Stem Cell TransplantationComplement Inactivating AgentsYoung AdultThrombotic MicroangiopathiesAntibodies, Monoclonal, Humanized

Keywords

EculizumabThrombotic microangiopathyBlockadeCohortHazard ratioProportional hazards modelComplement systemComplement component 5TransplantationComplementAllogeneic TransplantTa-tma